LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Standard BioTools Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERLAB
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / LAB COVERAGE

What’s moving Standard BioTools Inc. now

Current reporting with the operating signal separated from the noise.

01
Standard BioTools Inc.: Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction

Standard BioTools Inc.: Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction

The story matters when it changes Standard BioTools Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Standard BioTools Inc. (LAB) Discusses Merger and Strategic Rationale Prepared Remarks Transcript

Standard BioTools Inc. (LAB) Discusses Merger and Strategic Rationale Prepared Remarks Transcript

The story matters when it changes Standard BioTools Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Standard BioTools Inc.: Standard BioTools and Treeline Biosciences Announce Merger Agreement

Standard BioTools Inc.: Standard BioTools and Treeline Biosciences Announce Merger Agreement

The story matters when it changes Standard BioTools Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Standard BioTools Inc. CEO Michael Egholm to Present at 43rd Annual J.P. Morgan Healthcare Conference

Standard BioTools Inc. CEO Michael Egholm to Present at 43rd Annual J.P. Morgan Healthcare Conference

The story matters when it changes Standard BioTools Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
Earnings Call Transcript

Standard BioTools Inc. (LAB) CEO Michael Egholm on Q2 2022 Results

The story matters when it changes Standard BioTools Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest LAB filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-06 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-04 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-16 · Period 2025-12-31SEC ↗8-K/AMaterial company eventFiled 2026-07-29 · Period 2026-07-28SEC ↗8-KMaterial company eventFiled 2026-07-28 · Period 2026-07-24SEC ↗8-KMaterial company eventFiled 2026-07-24 · Period 2026-07-22SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-27 · Period 2026-06-17SEC ↗SCHEDULE 13G/AOfficial SEC filingFiled 2026-07-30SEC ↗
EARNINGS / QUARTERLY TRACKER

Standard BioTools Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.